Daniel Krell
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mixed Neuroendocrine and Non-neuroendocrine Tumor of Pancreato-Biliary Origin Treated Successfully with Peptide Receptor Radionuclide Therapy.
Journal: Journal of gastrointestinal cancer
Published: June 14, 2025
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
Journal: The Journal of pathology
Published: June 23, 2023
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
Journal: EClinicalMedicine
Published: March 27, 2023
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well-differentiated lung neuroendocrine tumours.
Journal: Journal of neuroendocrinology
Published: February 13, 2022
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours.
Journal: British journal of cancer
Published: July 18, 2018
Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 24, 2017
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.
Journal: PloS one
Published: December 28, 2015
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 19, 2015
IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.
Journal: Future oncology (London, England)
Published: December 04, 2013
Last Updated: 09/26/2026